封面
市場調查報告書
商品編碼
1750497

一次性手術器材市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Disposable Surgical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年,全球一次性手術器械市場規模達64億美元,預計2034年將以8.8%的複合年成長率成長,達到150億美元。這主要得益於手術量的成長、感染控制措施的加強以及全球對微創手術日益成長的偏好。一次性器械因其高效、易用且易於保持無菌狀態而日益受到青睞。隨著已開發經濟體和新興經濟體的醫療保健系統不斷精簡營運流程並降低交叉污染風險,一次性手術器械正成為當務之急。向自動化和符合人體工學的先進器材的轉變進一步推動了其應用,尤其是在高通量醫療環境中。

一次性手術器械市場 - IMG1

疫情爆發後,醫療機構遵守更嚴格的感染控制政策。這加速了一次性手術解決方案的普及,尤其是在擇期和急診手術數量回升的情況下。這些器械在衛生方面具有顯著優勢,無需消毒步驟,並縮短了手術室的周轉時間。它們專為一次性使用場景設計,在注重速度和病人安全的手術環境中發揮著至關重要的作用。從基礎工具到先進的縫合器和套管針,一次性器械在確保無菌條件的同時,也能提高手術的一致性。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 64億美元
預測值 150億美元
複合年成長率 8.8%

在產品類型中,手術縫線和縫合器領域在2024年以24億美元的市場規模領先市場。它們在傳統和微創手術中均已廣泛應用,是不可或缺的醫療工具。這些工具有助於傷口管理,確保傷口縫合牢固,最大限度地減少感染,並促進更快康復。人體工學設計、無需打結的倒鉤縫合線以及抗菌塗層等創新技術顯著提高了縫合線的安全性和效率,使其成為表現最佳的產品類別。

預計2034年,一般外科手術市場規模將達31億美元,複合年成長率為8.5%。此類別涵蓋多種手術,對一次性手術器械的需求持續成長。門診和住院干預的增加,以及慢性病和急性病的發生率不斷上升,正在推動對這些器械的需求。醫療機構依賴一次性手術器械來確保安全合規並簡化患者護理,尤其是在高容量環境中。

美國一次性手術器械市場規模在2024年達到20億美元,預計複合年成長率為7.7%。強大的監管框架、完善的醫療基礎設施以及優惠的報銷模式,都為一次性器械的快速普及提供了支援。此外,總部位於美國的大型醫療器材公司也持續推動市場的發展動能。

市場的主要參與者包括史密斯+侄子 (Smith+Nephew)、庫博 (CooperSurgical)、Xenco Medical、BD、強生 (Johnson & Johnson)、捷邁 (ZIMMER BIOMET)、貝朗 (B Braun)、美敦力 (Medtronic)、安布 (Ambu)、外科創新 (Surgifications) (Surgcut)、波士頓科學、安布 (Bocut)、外科創新。為了鞏固市場地位,各公司優先透過研發投資進行創新,以提高產品的可用性、安全性和性能。許多公司正在擴展產品組合,增加抗菌塗層和無結縫合線等智慧功能。與醫院和外科中心的策略合作也有助於確保供應合約並深化市場滲透。此外,製造商利用自動化和精密製造來滿足不斷成長的需求,同時保持成本效益,從而增強其在全球市場的競爭優勢。

目錄

第1章:方法論與範圍

第2章:執行摘要

第3章:行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 全球手術量不斷上升
      • 技術創新迅速
      • 嚴格的感染控制標準有利於一次性設備
      • 微創手術日益受到青睞
    • 產業陷阱與挑戰
      • 環境永續性議題
      • 成本和報銷障礙
  • 成長潛力分析
  • 監管格局
  • 川普政府關稅
    • 對貿易的影響
      • 貿易量中斷
      • 報復措施
    • 對產業的影響
      • 供應方影響(原料)
        • 主要材料價格波動
        • 供應鏈重組
        • 生產成本影響
      • 需求面影響(售價)
        • 價格傳導至終端市場
        • 市佔率動態
        • 消費者反應模式
    • 受影響的主要公司
    • 策略產業反應
      • 供應鏈重組
      • 定價和產品策略
      • 政策參與
    • 展望與未來考慮
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章:市場估計與預測:按產品,2021 - 2034 年

  • 主要趨勢
  • 手術縫合線和縫合器
  • 手持式手術設備
  • 免洗內視鏡設備
  • 電外科設備

第6章:市場估計與預測:按程序,2021 - 2034 年

  • 主要趨勢
  • 一般外科
  • 整形外科
  • 骨科手術
  • 心血管外科
  • 神經外科
  • 婦產科
  • 傷口閉合
  • 其他程式

第7章:市場估計與預測:依最終用途 2021 - 2034

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用途

第8章:市場估計與預測:按地區,2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章:公司簡介

  • Accutome
  • Ambu
  • B Braun
  • BD
  • Boston Scientific
  • CooperSurgical
  • Johnson & Johnson
  • Medtronic
  • Smith+Nephew
  • Surgical Innovations
  • Xenco Medical
  • ZIMMER BIOMET
簡介目錄
Product Code: 13893

The Global Disposable Surgical Devices Market was valued at USD 6.4 billion in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 15 billion by 2034, driven by increasing surgical volumes, heightened infection control measures, and the rising global preference for minimally invasive procedures. Disposable instruments are gaining traction due to their efficiency, ease of use, and ability to maintain sterile conditions. As healthcare systems across developed and emerging economies look to streamline operations and reduce the risk of cross-contamination, single-use surgical tools are becoming a top priority. The shift toward automation and ergonomically advanced tools further supports adoption, particularly in high-throughput medical settings.

Disposable Surgical Devices Market - IMG1

In the wake of the pandemic, healthcare providers adhere to stricter infection control policies. This has accelerated the move toward disposable surgical solutions, particularly as the number of elective and emergency procedures rebounds. These instruments offer clear benefits in hygiene, eliminate sterilization steps, and reduce turnaround times in operating rooms. Designed for single-use scenarios, they are proving vital in surgical environments that demand both speed and patient safety. From basic tools to advanced staplers and trocars, disposables ensure sterile conditions while improving procedural consistency.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$6.4 Billion
Forecast Value$15 Billion
CAGR8.8%

Among product types, the surgical sutures and staplers segment led the market with USD 2.4 billion in 2024. Their consistent usage in both traditional and minimally invasive procedures makes them indispensable. These tools help in wound management, ensuring proper closure, minimizing infections, and aiding faster recovery. Innovations like ergonomic designs, barbed sutures requiring no knots, and antimicrobial coatings have significantly enhanced their safety and efficiency, making them the top-performing product category.

The general surgery segment is projected to reach USD 3.1 billion by 2034, growing at a CAGR of 8.5%. This category covers several procedures, contributing to consistent demand for disposable surgical tools. The increasing rate of outpatient and inpatient interventions, along with the growing prevalence of chronic and acute conditions, is boosting demand for these devices. Medical institutions rely on single-use surgical tools for safety compliance and streamlined patient care, especially in high-volume environments.

U.S. Disposable Surgical Devices Market accounted for USD 2 billion in 2024 and is expected to grow at a CAGR of 7.7%. A strong regulatory framework, sophisticated healthcare infrastructure, and favorable reimbursement models all support rapid adoption of disposable instruments. Additionally, major medical device companies headquartered in the U.S. continue to drive market momentum.

Key players in this market include Smith+Nephew, CooperSurgical, Xenco Medical, BD, Johnson & Johnson, ZIMMER BIOMET, B Braun, Medtronic, Ambu, Surgical Innovations, Accutome, and Boston Scientific. To strengthen their foothold, companies prioritize innovation through R&D investments to enhance usability, safety, and performance. Many are expanding product portfolios with smart features such as antimicrobial coatings and knotless sutures. Strategic collaborations with hospitals and surgical centers are also helping secure supply contracts and deepen market penetration. Furthermore, manufacturers leverage automation and precision manufacturing to meet growing demand while maintaining cost-efficiency, enhancing their competitive edge across global markets.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising global surgical volume
      • 3.2.1.2 Rapid technological innovation
      • 3.2.1.3 Stringent infection control standards favoring disposable devices
      • 3.2.1.4 Rising preference for minimally invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Environmental sustainability concerns
      • 3.2.2.2 Cost and reimbursement barriers
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Trump administration tariffs
    • 3.5.1 Impact on trade
      • 3.5.1.1 Trade volume disruptions
      • 3.5.1.2 Retaliatory measures
    • 3.5.2 Impact on the Industry
      • 3.5.2.1 Supply-side impact (raw materials)
        • 3.5.2.1.1 Price volatility in key materials
        • 3.5.2.1.2 Supply chain restructuring
        • 3.5.2.1.3 Production cost implications
      • 3.5.2.2 Demand-side impact (selling price)
        • 3.5.2.2.1 Price transmission to end markets
        • 3.5.2.2.2 Market share dynamics
        • 3.5.2.2.3 Consumer response patterns
    • 3.5.3 Key companies impacted
    • 3.5.4 Strategic industry responses
      • 3.5.4.1 Supply chain reconfiguration
      • 3.5.4.2 Pricing and product strategies
      • 3.5.4.3 Policy engagement
    • 3.5.5 Outlook and future considerations
  • 3.6 Technology landscape
  • 3.7 Future market trends
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Surgical sutures and staplers
  • 5.3 Handheld surgical devices
  • 5.4 Disposable endoscopy devices
  • 5.5 Electrosurgical devices

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 General surgery
  • 6.3 Plastic and reconstructive Surgery
  • 6.4 Orthopedic surgery
  • 6.5 Cardiovascular surgery
  • 6.6 Neurosurgery
  • 6.7 Obstetrics and gynecology
  • 6.8 Wound closure
  • 6.9 Other procedures

Chapter 7 Market Estimates and Forecast, By End Use 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Specialty clinics
  • 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Accutome
  • 9.2 Ambu
  • 9.3 B Braun
  • 9.4 BD
  • 9.5 Boston Scientific
  • 9.6 CooperSurgical
  • 9.7 Johnson & Johnson
  • 9.8 Medtronic
  • 9.9 Smith+Nephew
  • 9.10 Surgical Innovations
  • 9.11 Xenco Medical
  • 9.12 ZIMMER BIOMET